相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen et al.
NATURE (2014)
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica
Tatsuro Misu et al.
ACTA NEUROPATHOLOGICA (2013)
Enzymatic Deglycosylation Converts Pathogenic Neuromyelitis Optica Anti-Aquaporin-4 Immunoglobulin G into Therapeutic Antibody
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2013)
Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients
Franz Heigl et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation
A. J. Ligocki et al.
GENES AND IMMUNITY (2013)
Specific peripheral B cell tolerance defects in patients with multiple sclerosis
Tuure Kinnunen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
IL-21 and CD40L Synergistically Promote Plasma Cell Differentiation through Upregulation of Blimp-1 in Human B Cells
B. Belinda Ding et al.
JOURNAL OF IMMUNOLOGY (2013)
Distinction and Temporal Stability of Conformational Epitopes on Myelin Oligodendrocyte Glycoprotein Recognized by Patients with Different Inflammatory Central Nervous System Diseases
Marie C. Mayer et al.
JOURNAL OF IMMUNOLOGY (2013)
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica
Hiroshi Kuroda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption
Rosetta Pedotti et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid
Nasrin Asgari et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica
Mark Woodhall et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
Manabu Araki et al.
MODERN RHEUMATOLOGY (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
Chao Quan et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
A. Harrer et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
Martin Stangel et al.
NATURE REVIEWS NEUROLOGY (2013)
The spectrum of MOG autoantibody-associated demyelinating diseases
Markus Reindl et al.
NATURE REVIEWS NEUROLOGY (2013)
Aquaporin water channels in the nervous system
Marios C. Papadopoulos et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
John S. Tzartos et al.
PLOS ONE (2013)
BAFF Controls Neural Cell Survival through BAFF Receptor
Satoru Tada et al.
PLOS ONE (2013)
Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
M. Leibinger et al.
CELL DEATH & DISEASE (2013)
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica Implication for Cellular Immune Responses
Bernd C. Kieseier et al.
JAMA NEUROLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
Maja Kitic et al.
Acta Neuropathologica Communications (2013)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis
Kevin Rostasy et al.
ARCHIVES OF NEUROLOGY (2012)
Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity
Sara J. Ireland et al.
AUTOIMMUNITY (2012)
Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
Aharon Kessel et al.
AUTOIMMUNITY REVIEWS (2012)
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Christina Elliott et al.
BRAIN (2012)
Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis
Aimin Wu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
Tobias Derfuss et al.
CURRENT OPINION IN NEUROLOGY (2012)
IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation
Ping Yang et al.
EXPERIMENTAL NEUROLOGY (2012)
Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica
Lukmanee Tradtrantip et al.
FASEB JOURNAL (2012)
Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells
Anneleen Bosma et al.
IMMUNITY (2012)
B cell exchange across the blood-brain barrier in multiple sclerosis
H. -Christian von Buedingen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Robert P. Lisak et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis
Mahdia Benkhoucha et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis
Michael J. Koziolek et al.
JOURNAL OF NEUROINFLAMMATION (2012)
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Markus C. Kowarik et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis
Marie Cathrin Mayer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey A. Cohen et al.
LANCET (2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Ayumi Yoshizaki et al.
NATURE (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Markus Krumbholz et al.
NATURE REVIEWS NEUROLOGY (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission
Stephanie Knippenberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Simone Mader et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
A. K. Proebstel et al.
NEUROLOGY (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H. L. Pellkofer et al.
NEUROLOGY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production
Kenichiro Maeda et al.
BLOOD (2010)
Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
Sema Icoz et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
IL-10 Mediates Resistance to Adoptive Transfer Experimental Autoimmune Encephalomyelitis in MyD88(-/-) Mice
Shmuel J. Cohen et al.
JOURNAL OF IMMUNOLOGY (2010)
Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
Min Yang et al.
JOURNAL OF IMMUNOLOGY (2010)
A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis
A. J. Ligocki et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius et al.
NATURE REVIEWS NEUROLOGY (2010)
Regulatory B cells in autoimmunity: developments and controversies
Claudia Mauri et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Johannes Brettschneider et al.
PLOS ONE (2010)
Atacicept: targeting B cells in multiple sclerosis
Hans-Peter Hartung et al.
Therapeutic Advances in Neurological Disorders (2010)
Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo
Monika Bradl et al.
ANNALS OF NEUROLOGY (2009)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Immunoglobulins and Complement in Postmortem Multiple Sclerosis Tissue
Michael H. Barnett et al.
ANNALS OF NEUROLOGY (2009)
A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Mariateresa Fulciniti et al.
CLINICAL CANCER RESEARCH (2009)
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis
Elizabeth M. Cameron et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor
Lei Zhang et al.
JOURNAL OF NEUROSCIENCE (2009)
The who, how and where of antigen presentation to B cells
Facundo D. Batista et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Homogeneity of active demyelinating lesions in established multiple sclerosis
Esther C. W. Breij et al.
ANNALS OF NEUROLOGY (2008)
B-cell tolerance checkpoints in health and autoimmunity
Eric Meffre et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome
Jeffrey L. Bennett et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica
S. Jarius et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
M. Krumbholz et al.
NEUROLOGY (2008)
Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology
Meizhang Li et al.
PROGRESS IN NEUROBIOLOGY (2008)
Follicular shuttling of marginal zone B cells facilitates antigen transport
Guy Cinamon et al.
NATURE IMMUNOLOGY (2008)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
Kevin C. O'Connor et al.
NATURE MEDICINE (2007)
Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein
PL Zhang et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
E Meinl et al.
ANNALS OF NEUROLOGY (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
M Mihara et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange
M Keegan et al.
LANCET (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
R Lesley et al.
IMMUNITY (2004)
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices
M Pizzi et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
Going both ways: immune regulation via CD1d-dependent NKT cells
DI Godfrey et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
The V-H gene repertoire of splenic B cells and somatic hypermutation in systemic lupus erythematosus
NLW Fraser et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells
A Valerio et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs
AF de Vos et al.
JOURNAL OF IMMUNOLOGY (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
Stimulation of myelin gene expression in vitro and of sciatic nerve remyelination by interleukin-6 receptor-interleukin-6 chimera
S Haggiag et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
分享论文
